Can kidney problems cause high c-peptide?

Kidney problems can cause high C-peptide levels because the kidneys are responsible for clearing C-peptide from the blood. When kidney function declines, C-peptide accumulates in the bloodstream, leading to elevated levels that may not accurately reflect insulin production.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding C-Peptide and Its Role in Your Body

C-peptide is a protein that your pancreas releases alongside insulin whenever you produce this vital hormone. Think of C-peptide as insulin's companion - for every molecule of insulin your body makes, it produces an equal amount of C-peptide. This one-to-one relationship makes C-peptide an excellent marker for understanding how much insulin your pancreas is producing.

Unlike insulin, which gets quickly used up by your cells, C-peptide stays in your bloodstream longer and is primarily removed by your kidneys. This longer half-life makes C-peptide testing particularly useful for assessing pancreatic function. Doctors often use C-peptide tests to distinguish between type 1 and type 2 diabetes, monitor insulin production, and evaluate hypoglycemia causes.

Normal C-peptide levels typically range from 0.5 to 2.0 nanograms per milliliter (ng/mL) when fasting, though these values can vary between laboratories. Understanding your C-peptide levels can provide valuable insights into your metabolic health and help guide treatment decisions. Regular monitoring through comprehensive metabolic testing can help you track changes over time and optimize your health outcomes.

C-Peptide Levels by Kidney Function Stage

CKD StageeGFR (mL/min/1.73m²)Expected C-Peptide ElevationClinical Consideration
Stage 1Stage 1≥90Normal to slightly elevatedStandard interpretation applies
Stage 2Stage 260-89Up to 1.5x normalMinor adjustment needed
Stage 3Stage 330-591.5-3x normalSignificant adjustment required
Stage 4Stage 415-293-5x normalMajor interpretation changes
Stage 5Stage 5<15>5x normalC-peptide unreliable marker

C-peptide elevation varies with kidney disease severity. Values are approximate and individual variation exists.

How Kidneys Process and Clear C-Peptide

Your kidneys play a crucial role in maintaining proper C-peptide levels in your blood. These remarkable organs filter approximately 70% of the C-peptide from your bloodstream, breaking it down and eliminating it through urine. This process happens continuously, helping maintain the delicate balance of proteins and hormones in your body.

The kidney's filtration system, particularly the glomeruli (tiny blood vessels that act as filters), is responsible for removing C-peptide along with other waste products. When your kidneys function normally, they efficiently clear C-peptide at a predictable rate, which is why C-peptide levels remain relatively stable in healthy individuals.

However, this efficient clearance system means that any disruption in kidney function can significantly impact C-peptide levels. Even mild decreases in kidney function can lead to C-peptide accumulation, as the clearance rate slows down while production continues at the same pace.

The Connection Between Kidney Disease and Elevated C-Peptide

When kidney function declines, whether due to chronic kidney disease (CKD), acute kidney injury, or other renal conditions, the ability to clear C-peptide from the blood diminishes. This reduced clearance leads to C-peptide accumulation, resulting in elevated blood levels that may not accurately reflect actual insulin production by the pancreas.

Research has shown that C-peptide levels can increase by 2-5 times in patients with moderate to severe kidney disease compared to those with normal kidney function. This elevation occurs even when insulin production remains unchanged, making it challenging to interpret C-peptide results in the context of kidney disease. Understanding these relationships is crucial for proper diagnosis and treatment planning.

The relationship between kidney function and C-peptide levels is particularly important for people with diabetes who also have kidney complications. Diabetic nephropathy, a common complication of both type 1 and type 2 diabetes, can significantly affect C-peptide clearance and complicate the interpretation of test results.

Stages of Kidney Disease and C-Peptide Impact

The impact on C-peptide levels varies depending on the stage of kidney disease. In early stages (CKD stages 1-2), when kidney function is only mildly reduced, C-peptide levels may show minimal elevation. However, as kidney disease progresses to stages 3-5, the accumulation of C-peptide becomes more pronounced, with levels potentially reaching several times the normal range.

Other Factors Contributing to High C-Peptide

While kidney disease is a significant cause of elevated C-peptide, other factors can also contribute to high levels. These include insulin resistance, type 2 diabetes, insulinomas (insulin-producing tumors), and certain medications. Additionally, obesity and metabolic syndrome often present with elevated C-peptide levels due to increased insulin production in response to insulin resistance.

Clinical Implications of High C-Peptide with Kidney Disease

For healthcare providers, interpreting C-peptide levels in patients with kidney disease requires careful consideration of renal function. Standard reference ranges may not apply, and adjustments based on estimated glomerular filtration rate (eGFR) or creatinine levels are often necessary. This complexity underscores the importance of comprehensive testing that includes both metabolic and kidney function markers.

Misinterpretation of elevated C-peptide levels in kidney disease patients can lead to incorrect diagnoses or treatment decisions. For example, high C-peptide levels might be mistakenly attributed to excessive insulin production when the real cause is reduced kidney clearance. This distinction is crucial for appropriate diabetes management and avoiding unnecessary interventions.

Diagnostic Challenges and Solutions

To accurately assess pancreatic function in patients with kidney disease, clinicians often need to use alternative approaches or adjust their interpretation of C-peptide results. Some strategies include using C-peptide to creatinine ratios, considering the degree of kidney impairment when interpreting results, or relying more heavily on clinical presentation and other diagnostic tests.

Testing and Monitoring Strategies

If you have kidney disease or risk factors for kidney problems, regular monitoring of both kidney function and metabolic markers becomes essential. A comprehensive approach should include tests for creatinine, eGFR, blood urea nitrogen (BUN), along with C-peptide and other diabetes-related markers. This holistic view helps healthcare providers make more informed decisions about your care.

The frequency of testing depends on your individual situation, but those with known kidney disease typically need monitoring every 3-6 months. This regular testing helps track disease progression and allows for timely adjustments to treatment plans. Home testing options have made it easier than ever to stay on top of these important health markers without frequent trips to the laboratory.

Key Tests to Consider

  • C-peptide levels (with consideration of kidney function)
  • Serum creatinine and eGFR for kidney function assessment
  • Hemoglobin A1c for long-term glucose control
  • Fasting glucose and insulin levels
  • Urinary albumin for early kidney damage detection
  • Complete metabolic panel for overall health status

Managing Your Health with Kidney Disease and Metabolic Concerns

Living with kidney disease requires a multifaceted approach to health management. Beyond monitoring C-peptide and other biomarkers, lifestyle modifications play a crucial role in slowing disease progression and maintaining metabolic health. These modifications include following a kidney-friendly diet, managing blood pressure and blood sugar, staying physically active within your limitations, and maintaining a healthy weight.

Dietary considerations are particularly important, as certain foods can affect both kidney function and metabolic health. Working with a registered dietitian who specializes in kidney disease can help you develop a meal plan that supports both your kidney health and metabolic needs. This might include limiting protein, phosphorus, and potassium while ensuring adequate nutrition for overall health.

Medication Considerations

If you're taking medications for diabetes or other conditions, kidney disease may affect how your body processes these drugs. Dose adjustments are often necessary as kidney function declines, and some medications may need to be avoided entirely. Regular monitoring helps ensure that your medication regimen remains safe and effective as your kidney function changes.

Looking Forward: Monitoring and Prevention

Understanding the relationship between kidney function and C-peptide levels empowers you to take a more active role in your health management. By recognizing that elevated C-peptide levels may reflect kidney dysfunction rather than just metabolic issues, you can work with your healthcare team to develop a more targeted and effective treatment plan.

Prevention remains the best strategy for avoiding complications from both kidney disease and metabolic disorders. This includes maintaining healthy blood pressure and blood sugar levels, staying hydrated, avoiding nephrotoxic substances, and getting regular check-ups to catch problems early. Early detection and intervention can significantly slow the progression of kidney disease and help maintain better metabolic health.

Regular biomarker testing provides the data needed to track your progress and make informed decisions about your health. By monitoring trends over time rather than focusing on single test results, you and your healthcare provider can better understand how your body is responding to treatment and make adjustments as needed. This proactive approach to health monitoring is key to achieving optimal outcomes despite the challenges of kidney disease.

References

  1. Pham, H., Robinson-Cohen, C., Biggs, M. L., Ix, J. H., Mukamal, K. J., Fried, L. F., Kestenbaum, B., Siscovick, D. S., & de Boer, I. H. (2012). Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clinical Journal of the American Society of Nephrology, 7(4), 588-594.[Link][PubMed][DOI]
  2. Covic, A., Schiller, A., Constantinescu, O., Iacob, S., Apetrii, M., & Mardare, N. (2008). The impact of C-peptide status on the progression of diabetic nephropathy. European Journal of Internal Medicine, 19(8), 580-585.[PubMed][DOI]
  3. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803-817.[Link][PubMed][DOI]
  4. Little, R. R., Rohlfing, C. L., Tennill, A. L., Madsen, R. W., Polonsky, K. S., Myers, G. L., Greenbaum, C. J., Palmer, J. P., Rogatsky, E., & Stein, D. T. (2008). Standardization of C-peptide measurements. Clinical Chemistry, 54(6), 1023-1026.[Link][PubMed][DOI]
  5. Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475-487.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide at home?

You can test your C-peptide at home with SiPhox Health's Heart & Metabolic Program or Ultimate 360 Health Program. Both programs include C-peptide testing along with comprehensive metabolic and kidney function markers, providing lab-quality results from the comfort of your home.

What is the normal range for C-peptide if I have kidney disease?

Normal C-peptide ranges need adjustment based on kidney function. While typical ranges are 0.5-2.0 ng/mL, levels can be 2-5 times higher with kidney disease. Your healthcare provider should interpret results considering your eGFR and creatinine levels for accurate assessment.

Can high C-peptide levels damage my kidneys?

High C-peptide levels themselves don't damage kidneys. Rather, kidney disease causes C-peptide accumulation. However, the underlying conditions causing elevated C-peptide, such as diabetes or insulin resistance, can contribute to kidney damage over time if not properly managed.

Should I stop diabetes medications if my C-peptide is high due to kidney disease?

Never stop medications without consulting your healthcare provider. High C-peptide from kidney disease doesn't mean you're producing too much insulin. Your doctor needs to evaluate your overall condition, including kidney function, before making any medication adjustments.

How often should I test C-peptide if I have kidney problems?

Most experts recommend testing every 3-6 months if you have kidney disease, along with regular kidney function tests. More frequent monitoring may be needed if your condition is changing rapidly or if you're adjusting medications.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details